Medtronic Shares Outstanding 2006-2018 | MDT

Medtronic shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Medtronic shares outstanding for the quarter ending July 31, 2018 were 1.365B, a 0.74% decline year-over-year.
  • Medtronic 2018 shares outstanding were 1.368B, a 1.67% decline from 2017.
  • Medtronic 2017 shares outstanding were 1.391B, a 2.42% decline from 2016.
  • Medtronic 2016 shares outstanding were 1.426B, a 28.58% increase from 2015.
Medtronic Annual Shares Outstanding
(Millions of Shares)
2018 1,368
2017 1,391
2016 1,426
2015 1,109
2014 1,014
2013 1,028
2012 1,060
2011 1,082
2010 1,109
2009 1,126
2008 1,144
2007 1,162
2006 1,217
2005 1,221
Medtronic Quarterly Shares Outstanding
(Millions of Shares)
Q1 2018 1,365
Q4 2018 1,368
Q3 2018 1,354
Q2 2017 1,366
Q1 2017 1,376
Q4 2017 1,391
Q3 2017 1,383
Q2 2016 1,393
Q1 2016 1,407
Q4 2016 1,426
Q3 2016 1,422
Q2 2015 1,429
Q1 2015 1,436
Q4 2015 1,109
Q3 2015 996
Q2 2014 993
Q1 2014 1,005
Q4 2014 1,014
Q3 2014 1,010
Q2 2013 1,009
Q1 2013 1,021
Q4 2013 1,028
Q3 2013 1,021
Q2 2012 1,028
Q1 2012 1,037
Q4 2012 1,060
Q3 2012 1,060
Q2 2011 1,063
Q1 2011 1,070
Q4 2011 1,082
Q3 2011 1,078
Q2 2010 1,084
Q1 2010 1,090
Q4 2010 1,109
Q3 2010 1,109
Q2 2009 1,109
Q1 2009 1,115
Q4 2009 1,126
Q3 2009 1,122
Q2 2008 1,131
Q1 2008 1,132
Q4 2008 1,144
Q3 2008 1,135
Q2 2007 1,148
Q1 2007 1,153
Q4 2007 1,162
Q3 2007 1,164
Q2 2006 1,159
Q1 2006 1,165
Q4 2006 1,217
Q3 2006 1,223
Q2 2005 1,223
Q1 2005 1,223
Q4 2005 1,221
Q3 2005 1,219
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $124.342B $29.953B
Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $122.048B 24.73
Stryker (SYK) United States $62.796B 23.67
Boston Scientific (BSX) United States $50.730B 25.64
Baxter (BAX) United States $33.541B 21.66
Zimmer Biomet Holdings (ZBH) United States $23.031B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.007B 0.00
ResMed (RMD) United States $14.492B 27.64
Canopy Growth (CGC) Canada $8.934B 0.00
Perrigo (PRGO) Ireland $8.884B 13.48
Bio-Rad Laboratories (BIO) United States $8.054B 51.50
Aurora Cannabis (ACB) Canada $6.462B 35.26
Hill-Rom Holdings (HRC) United States $6.201B 19.66
Haemonetics (HAE) United States $5.495B 48.33
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.529B 25.23
Hutchison China MediTech (HCM) China $4.274B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.987B 0.00
Agios Pharmaceuticals (AGIO) United States $3.869B 0.00
Neogen (NEOG) United States $3.219B 48.74
National Vision Holdings (EYE) United States $3.101B 61.33
NuVasive (NUVA) United States $2.972B 27.65
Aphria (APHA) $2.572B 0.00
Quidel (QDEL) United States $2.478B 32.30
NxStage Medical (NXTM) United States $1.924B 0.00
Phibro Animal Health (PAHC) United States $1.476B 20.89
AtriCure (ATRC) United States $1.174B 0.00
Cardiovascular Systems (CSII) United States $1.015B 1462.50
VAREX IMAGING (VREX) United States $0.992B 19.93
Meridian Bioscience (VIVO) United States $0.827B 26.35
PetIQ (PETQ) United States $0.803B 22.83
OraSure Technologies (OSUR) United States $0.793B 44.65
Surmodics (SRDX) United States $0.776B 118.55
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.22
Cerus (CERS) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.710B 0.00
Omeros (OMER) United States $0.623B 0.00
Lantheus Holdings (LNTH) United States $0.590B 18.27
Owens & Minor (OMI) United States $0.558B 6.31
Insys Therapeutics (INSY) United States $0.542B 0.00
LeMaitre Vascular (LMAT) United States $0.518B 25.45
NanoString Technologies (NSTG) United States $0.481B 0.00
TG Therapeutics (TGTX) United States $0.438B 0.00
Evolus (EOLS) United States $0.399B 0.00
Quanterix (QTRX) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.302B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.255B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
BioLife Solutions (BLFS) United States $0.206B 278.75
Bovie Medical (BVX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.161B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.148B 0.00
Fonar (FONR) United States $0.139B 6.96
Chembio Diagnostics (CEMI) United States $0.104B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.081B 0.00
United-Guardian (UG) United States $0.079B 16.63
Female Health (VERU) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.077B 24.40
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Valeritas Holdings (VLRX) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00